Bone Biologics Corp Warrants
BBLGW
2 hedge funds and large institutions have $2.02M invested in Bone Biologics Corp Warrants in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
254% more capital invested
Capital invested by funds: $570K → $2.02M (+$1.45M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
2.67% less ownership
Funds ownership: 6.27% → 3.6% (-2.7%)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$95.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.39K |
| 2 |
CS
Clear Street
New York
|
-$1.72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $2.02M | +$95.7K | +3,723 | +11% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $78 | -$2.39K | -93 | -93% |
|
|
CS
3
Clear Street
New York
| – | -$1.72K | -100 | Closed |
|
BBLGW Hedge Fund Activity: Q2 2024 in Review
2 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q2 2024, worth a combined $2.02M — up 254% from $570K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BBLGW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $95.7K. The largest seller was Bank of America, cutting an estimated $2.39K.
- 2 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q2 2024, down from 3 in Q1 2024.
- Funds reported $2.02M of Bone Biologics Corp Warrants stock for Q2 2024, up 254% quarter-over-quarter.
- 0 funds opened new Bone Biologics Corp Warrants positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Bone Biologics Corp Warrants buyer in Q2 2024 was Citadel Advisors, an estimated $95.7K added.
- The largest Bone Biologics Corp Warrants seller in Q2 2024 was Bank of America, an estimated $2.39K sold.
Based on aggregated 13F filings for Q2 2024.